Sunday, March 24, 2019

Johnson & Johnson on Thursday said it will record a nearly $700 million impairment charge in the first quarter of 2019 related to the abandoned development of its experimental antiviral drug, AL-8176.


from Reuters: Health News https://ift.tt/2Tqqdax

Related Posts:

  • LATEST HEALTH NEWSThailand approved marijuana for medical use and research on Tuesday, the first legalization of the drug in a region with some of the world's strictest drug laws. from Reuters: Health News https://reut.rs/2Sl7YDU … Read More
  • LATEST HEALTH NEWS(Reuters Health) - Professional athletes in the National Basketball Association may score fewer points and snag fewer rebounds the day after late-night activity on Twitter, a new study suggests. from Reuters: Health News… Read More
  • LATEST HEALTH NEWS(Reuters Health) - Doctor moms regularly run up against discrimination, sometimes subtle and sometimes blatant, a new survey finds. from Reuters: Health News https://reut.rs/2LwWSsZ … Read More
  • LATEST HEALTH NEWSChina has detected the African swine fever virus in some protein powders made using pork blood and manufactured by a Tianjin-based company, the General Administration of Customs said in a statement on Tuesday. from Reute… Read More
  • LATEST HEALTH NEWS(Reuters Health) - Forcing patients off opioid painkillers could sometimes do more harm than good, international medical experts warn in an open letter to health authorities. from Reuters: Health News https://reut.rs/2Sf… Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner